• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPECTRANETICS STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPECTRANETICS STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER Back to Search Results
Model Number A35SX050040135
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Gangrene (1873); Unspecified Infection (1930); Necrosis (1971)
Event Date 12/23/2019
Event Type  Injury  
Manufacturer Narrative
The patient required amputation on the treated limb.This is being reported as a follow-up to the clinical registry.Cross reference mfr report number: 3009784280-2020-00151.Patient information regarding relevant tests or laboratory data is unknown.This information was not available from the facility.(b)(6).Pma number is not applicable.The device is a commercial product with a ce mark that was used as part of a clinical registry.During the index procedure, the product worked as intended and the device was discarded, thus no product evaluation was required.Although the cause of amputation is unrelated to the study device; amputation, necrosis, and infection are listed as potential complications/ adverse events.
 
Event Description
It was reported through a clinical registry that during the index procedure on (b)(6) 2019, two stellarex catheters were used to treat the target lesion of the right mid sfa and popliteal p1.Approximately 2 weeks post index procedure, the patient experienced gangrene and necrosis.A major amputation of the right lower leg was performed on (b)(6) 2019.Eighteen days later, the patient experienced a non-healing wound and necrosis on the amputation site.Additional amputation of the right lower leg was performed on (b)(6) 2019.Approximately 1 month later, the patient experienced an infection.Additional amputation of the right upper leg, at the knee area was performed on (b)(6) 2019.The physician indicated this is not related to the study device or procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON
Type of Device
DCB PTA CATHETER
Manufacturer (Section D)
SPECTRANETICS
6531 dumbarton circle
fremont CA 94555
Manufacturer (Section G)
SPECTRANETICS
6531 dumbarton circle
fremont CA 94555
Manufacturer Contact
diana melliza galvez
5055 brandin court
fremont, CA 94538
510933-791
MDR Report Key10116920
MDR Text Key194116224
Report Number3009784280-2020-00152
Device Sequence Number1
Product Code ONU
Combination Product (y/n)Y
Reporter Country CodeAU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,study
Reporter Occupation Physician
Type of Report Initial
Report Date 01/01/2005,05/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/03/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/17/2020
Device Model NumberA35SX050040135
Device Catalogue NumberA35SX050040135
Device Lot NumberFCZ18D20A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received05/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age74 YR
Patient Weight83
-
-